Cargando…
A novel peptide that inhibits E2F transcription and regresses prostate tumor xenografts
E2F-1, a key transcription factor necessary for cell growth, DNA repair and differentiation, is an attractive target for development of useful anticancer drugs in tumors that are E2F “oncogene addicted”. A peptide, isolated from phage clones, based on its binding to an E2F-1 consensus sequence, was...
Autores principales: | Xie, Xiaoqi, Bansal, Nitu, Shaik, Tazeem, Kerrigan, John E., Minko, Tamara, Garbuzenko, Olga, Abali, Emine Ercikan, Johnson-Farley, Nadine, Banerjee, Debabrata, Scotto, Kathleen W., Bertino, Joseph R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011592/ https://www.ncbi.nlm.nih.gov/pubmed/24658650 |
Ejemplares similares
-
Modeling and antitumor studies of a modified L–penetratin peptide targeting E2F in lung cancer and prostate cancer
por: Shaik, Tazeem, et al.
Publicado: (2018) -
Bioquímica /
por: Abali, Emine Ercikan
Publicado: (2022) -
Anti-Tumor Effects of a Penetratin Peptide Targeting Transcription of E2F-1, 2 and 3a Is Enhanced When Used in Combination with Pemetrexed or Cisplatin
por: Rather, Gulam Mohmad, et al.
Publicado: (2021) -
Non-viral systemic delivery of siRNA or antisense oligonucleotides targeted to Jun N-terminal kinase 1 prevents cellular hypoxic damage
por: Betigeri, Seema, et al.
Publicado: (2010) -
Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention
por: Garbuzenko, Olga B., et al.
Publicado: (2014)